It is an individual R&D project, led by Adventia, which develops a diet with new food products which are nutritional and in a sensory way suitable for cancer patients
Thanks to Alisenoc, in the year 2021, cancer patients will thus have high-quality nutritional supplements with innovative ingredients and a wide range of flavours.
With the objective of improving the nutritional state and quality of life of patients.
For scientific backing, a clinical trial will be carried out with the participation of the following entities: 
The Alisenoc project is co-financed by the CDTI (Industrial Technological Development Centre) with ERDF funds from the European Union.

“In accordance with article 15 of the Spanish Law on Guarantees and Rational Use of Medicines and Healthcare products, the information set out in the following sections is aimed for healthcare professionals who carry out their activities in Spain and are subject to Spanish law.”
“Under no circumstances does ADVENTIA assume any liability for any injury that might result from illegal or improper use of this website. Both access to this web site and the use made of the information contained herein is the exclusive responsibility of the user.”